Continuous Infusion of Ropivacaine Hydrochloride in Reducing Pain After Surgery in Patients With Bladder Cancer
|
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
| ClinicalTrials.gov Identifier: NCT02438852 |
|
Recruitment Status :
Withdrawn
(No funding)
First Posted : May 8, 2015
Last Update Posted : April 16, 2019
|
Sponsor:
University of Southern California
Collaborator:
National Cancer Institute (NCI)
Information provided by (Responsible Party):
University of Southern California
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
Study was withdrawn before participants were enrolled.
| Recruitment Status : | Withdrawn |
|---|---|
| Estimated Primary Completion Date : | February 25, 2021 |
| Estimated Study Completion Date : | February 25, 2022 |